Update publication information. Our findings suggest that DIA combined with PRM mass spectrometric method was effective in identifying and validating the candidate biomarkers for several diseases including EGPA diagnosis. We have discovered and validated three new potentially serum biomarkers FGA, SAP and CETP for discriminating EGPA from severe asthma groups. These potential biomarkers might be of great importance to diagnosis EGPA.